research LB1256 TRIV-509, a dual inhibitor of KLK5 and KLK7, rapidly improves barrier integrity and markers of epidermal differentiation in atopic dermatitis skin explants
TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.
Search
for
Sort by
Research
750-780 / 1000+ results
research Outgoing ABHRS President’s Corner
The document's content could not be processed.
research Lactobacillus paracasei HY7015 Promotes Hair Growth in a Telogenic Mouse Model
Lactobacillus paracasei HY7015 helps hair grow in mice.
research Accolades for Australia
The document's conclusion cannot be provided because the document is not accessible or understandable.
research Pioneer's Page
The document could not be read or understood.
research ISID0197 - Quantitative analysis of hair loss in mice utilizing imageJ improves the efficacy evaluation of alopecia areata induction in the C3H/HeJ mouse model
A new image-based method improves accuracy in measuring hair loss in mice.
research 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial
CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.
research Comments from the Assistants' Editor
research The Influence of Cyproteron-Acetate Orally on the Hair Root Status in Women with Idiopathic Hirsutism
research The Promoting Effect of Ishige sinicola on Hair Growth
Ishige sinicola, a type of seaweed, may help hair grow by blocking a hair loss-related enzyme and boosting important cell growth.
research Letters to the Editors: Re: FUE and donor planning
The document's conclusion cannot be provided because the content is not available to parse.
research TRICHOGRAM OBSERVATION OF ORAL IVERMECTIN THERAPY IN SCABIOSIS AND OTITIS EXTERNA IN DOMESTIC CATS
Oral ivermectin effectively treated a cat's mite infections, improving its condition.
research A Clinical Study of Androgenetic Alopecia(IV)
research Selective isomerization of α-pinene oxide to campholenic aldehyde by ionic liquid-supported indenyl-molybdenum(II)-bipyridine complexes
The process efficiently converts α-pinene oxide to campholenic aldehyde using a special catalyst, achieving high yields quickly.
research Review of the Literature
I'm sorry, but I can't provide a conclusion without the content of the document.
research Review of the Literature
I'm sorry, but I can't provide a conclusion without the content of the document.
research Review of the Literature
I'm sorry, but I can't provide a conclusion without the content of the document.
research Review of the Literature
I'm sorry, but I can't provide a conclusion without the content of the document.
research Review of the Literature
I'm sorry, but I can't provide a conclusion without the content of the document.
research Abhrs Recognition
The document's conclusion cannot be summarized because the content is not understandable.
research Cover Image
research Pioneer of the Month
The document's conclusion cannot be summarized because the content is not accessible or understandable.
research 861 EGFR/MEK inhibitor therapy induces partial hair follicle immune privilege collapse in vivo and ex vivo
research Baricitinib as a treatment for myasthenia gravis: A case report
Baricitinib successfully treated myasthenia gravis and alopecia in a patient.
research Preformulation studies of finasteride to design matrix systems for topical delivery
research Bio insecticide of dayak onion extract (Eleutherine palmifolia (L.) Merr) against the mortality of hair lice (Pediculus humanus capitis) on the incidence of pediculosi capitis at orphanages in Palembang city, Indonesia
research Know your board members
The document's conclusion cannot be summarized because the content is not accessible.
research 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.